Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Keytruda
Active Ingredient: Pembrolizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: MSD International GmbH (Ireland), Carlow, Ireland
   
Product: Keytruda
Active Ingredient: Pembrolizumab 50mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: MSD International GmbH, Innishannon, Ireland
   
Product: Yaz
Active Ingredients: Drospirenone 3mg
Ethinylestradiol betadex clathrate equivalent to ethinylestradiol 0.02mg
Dosage Form: Tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturers: Bayer Weimar GmbH und Co KG, Weimar, Germany
Bayer AG, Leverkusen, Germany
   

Dated this 19th day of July 2019.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).